Cormorant Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-585,462	Closed	-$15.6M	–	50
2024 Q4	$15.6M	Hold	585,462	–	–	0.86%	28
2024 Q3	$13.8M	Buy	585,462 +70,462	+14%	+$1.66M	0.73%	34
2024 Q2	$9.55M	Hold	515,000	–	–	0.55%	35
2024 Q1	$9.2M	Buy	+515,000	New	+$9.2M	0.4%	46